Controlled release dosage forms
US8323692B2 · kind B2 · utility
29Cited by
18References
37Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 5, 2008 |
| Grant date | Dec 4, 2012 |
| Priority date | — |
| Expiry date | Jan 11, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55° C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.